New age lung carcinogenesis: clinical impact

Hot topics
Chairs: C. Brambilla (Grenoble, France), R. M. Huber (Munich, Germany)
Aims: To provide the most recent information on biomarker strategies to select patients by individual risk and predict the success of specific treatments.

Introduction: new age of lung carcinogenesis C. Brambilla (Grenoble, France)
Harvesting biomarkers for early risk assessment P. Yang (Taipei, Taiwan, Province of China)